The Global Health Body Raises Concern Over Severe Scarcity of Weight-Loss Injections
Under a tenth of people eligible to benefit from obesity jabs including Wegovy are able to get them, caution the World Health Organization as it issues its inaugural guidance on the medications.
With in excess of 1,000,000,000 people worldwide currently living with obesity, it is calling for broader and more equitable access to this class of drugs.
According to estimates, in excess of 2,000,000,000 are projected to be living with obesity by 2030 if no action is taken.
"Our latest guidance recognises that excess weight is a lifelong illness that can be treated with thorough and ongoing treatment," remarked WHO director-general Tedros Adhanom Ghebreyesus.
Substantial prices, insufficient output, and distribution challenges are key hurdles to broad access to the treatments that can assist patients in reducing substantial weight, says the body.
GLP-1 Therapy Supply Crisis
Despite the current most favorable outlook, the manufacturing of such drugs might only reach about 100 million people – less than 10% of eligible patients, per the health organization.
The guideline calls on nations and manufacturers to widen access, via strategies including patent sharing.
The intellectual property rights on the active ingredient – the main ingredient of the drug Wegovy – is scheduled to end in a number of countries in 2026.
The Way Obesity Injections Function
The injections replicate a natural hormone to delay gastric emptying, reduce hunger and enhance feelings of fullness so people eat less.
Individuals typically begin shedding pounds after several weeks of starting on the weekly injections.
Research points to patients may regain a significant portion within a year of stopping the drug, because their normal hunger return.
To be carrying excess weight raises your chance for contracting health problems, such as diabetes, heart disease, brain attack, and some cancers.
Excess weight impacts individuals in all nations and was responsible for millions of fatalities worldwide in 2024, per the WHO.